FindTrial
Sign In

Assessment of Treatment Outcomes for Esophageal and Gastric Varices Secondary to Portal Hypertension

Assessment of Treatment Outcomes for Esophageal and Gastric Varices Secondary to Portal Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118870
Enrollment
Unknown
Registered
2026-02-12
Start date
2026-02-23
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal hypertension

Interventions

Non-endoscopic treatment group:None
Endoscopic treatment group:None

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The age is over 18 years old, regardless of gender. 2. Clinical diagnosis of portal hypertension with esophagogastric varices. 3. Abdominal CT and gastroscopy were performed.

Exclusion criteria

Exclusion criteria: 1.Presence of peptic ulcer, gastric tumor, or other causes of gastrointestinal bleeding confirmed by imaging or gastroscopy; 2.CT images of inadequate quality or incomplete medical history data;

Design outcomes

Primary

MeasureTime frame
Survival;Rebleeding occurred one year later;—

Secondary

MeasureTime frame
Adverse events;1-year Mortality;Portal hypertension-related complications (including ascites, hepatic encephalopathy, portal vein thrombosis, etc.);—

Countries

China

Contacts

Public ContactChen.Shiyao

Zhongshan Hospital, Fudan University

chen.shiyao@zs-hospital.sh.cn+86 21 64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026